Trial Profile
A 24-week Trial of the Effectiveness and Safety of Fimasartan 60 mg Alone as Initial Treatment and Its Randomized Escalation to Fimasartan 120 mg or Fimasartan 60 mg/HCTZ 12.5 mg in Mexican Patients With Grade 1 and 2 Essential Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fimasartan/hydrochlorothiazide (Primary) ; Fimasartan
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Acronyms FIRME-1
- 25 Jun 2015 New trial record